Japanese Clinical Practice Guidelines for Rehabilitation in Critically Ill Patients 2023 (J-ReCIP 2023)
Takeshi Unoki(Sapporo City University), Tadashi Nagato(Tokyo Yamate Medical Center), Shunsuke Taito(Hiroshima University Hospital), Kazuki Okura(Akita University Hospital), Asuka Tsuchiya(Tokai University), Akira Kuriyama(Kyoto University), Shodai Yoshihiro(Hiroshima University Hospital), Masatsugu Okamura(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Akira Ouchi(Ibaraki Christian University), Satoshi Endo, Fumihito Kasai(SHOWA Medical University), Masanari Kuwabara(Jichi Medical University), Naoki Sasanuma, Masakazu Saitoh(Juntendo University), Ryuichi Kusaba(Kyushu University Hospital), Yukiko Katayama(Sakakibara Hospital), Junko Tatsuno(Kokura Memorial Hospital), Kei Hayashida(Northwell Health), Yusuke Tsutsumi(National Hospital Organization Mito Medical Center), Takahisa Otsuka(Okayama University Hospital), Taisuke Yasaka(The University of Tokyo), Ryo Kozu(Nagasaki University Hospital), Takahiko Tamura(Kochi Medical School Hospital), N. Tashiro(Showa University Hospital), Mitsuhiro Tamoto(Kyoto University Hospital), Tatsuya Kawasaki(Shizuoka Children's Hospital), Yuki Uchiyama, Hiroyasu Inoue(University of the Sciences), Mio Kitayama(Kanazawa Medical University Hospital), Yusuke Kawai(Fujita Health University Hospital), Chihiro Takayama, Yujiro Matsuishi(St. Luke's International University), Tomoki Kuribara(Sapporo City University), Saiko Okamoto(Hitachi General Hospital), Daisuke Okada(Saiseikai Kumamoto Hospital), Kensuke Nakamura(Hitachi General Hospital), Yutaka Kondo(Juntendo University Urayasu Hospital), Hideaki Sakuramoto(Japanese Red Cross Kyushu International College of Nursing), Norimasa Yamamoto(Toyama Prefectural Central Hospital), Nobuyuki Sasaki(St. Marianna University School of Medicine), Ryo Abe(Tokyo University of Science), Yuki Iida(Toyohashi SOZO University), Morihide Ando(Ogaki Municipal Hospital), Naoki Kaneda(National Hospital Organization Hokkaido Medical Center), Kengo Obata(Okayama Red Cross General Hospital), Kohei Ota(Hiroshima University), Ryuichi Saura(Osaka University of Pharmaceutical Sciences), Shunsuke Kina, Takahito Iitsuka(Hyogo Prefectural Amagasaki General Medical Center), Masahiro Takahashi(Sapporo City General Hospital)
Cited by 60
Related Papers
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
|Journal of Biological Chemistry|1998|792
Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018
|The Journal of Pediatrics|2020|203
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives
|Journal of Clinical Medicine|2021|91
Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan
|JAMA Pediatrics|2022|89
Update in uric acid, hypertension, and cardiovascular diseases
|Hypertension Research|2023|85